Corsair Capital Management - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 82 filers reported holding RECRO PHARMA INC in Q2 2019. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.

Quarter-by-quarter ownership
Corsair Capital Management ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q2 2020$1,460,000
-51.1%
320,847
-12.2%
0.60%
-58.2%
Q1 2020$2,985,000
-81.1%
365,352
-57.5%
1.43%
-69.8%
Q4 2019$15,756,000
+42.7%
859,568
-13.7%
4.73%
+39.5%
Q3 2019$11,039,000
+46.1%
996,281
+34.1%
3.39%
+53.4%
Q2 2019$7,555,000742,9002.21%
Other shareholders
RECRO PHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders